Enter your login e-mail to the account
Search
Search parameters
Search results
- Sekundární dyslipoproteinémie
MUDr. Michal Vrablík, PhD., doc. MUDr. Richard Češka, CSc.
(1/2004, Main topic ) - Současnost a perspektivy léčby dyslipidémií
doc. MUDr. Jan Bultas, CSc., MUDr. Debora Karetová
(1/2004, Main topic ) - Epidemiologic situation in Slovakia – circulation disorders and their risk factors
MUDr. Anna Baráková
(1/2009, Topic of the year ) - Investigation of the obese patient in clinical practice
doc. MUDr. Boris Krahulec, CSc.
(2/2015, Topic of the year ) - Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - SECONDARY PREVENTION IN ACUTE MYOCARDIAL INFARCTION
MUDr. Branislav Tomašovič, MUDr. Marián Kozlovský
(1/2006, Topic ) - Obesity management in ambulatory practice
MUDr. Peter Minárik, MUDr. Dušan Ogurčák
(6/2009, Review articles ) - Classification of dyslipoproteinaemias: Part II – Secondary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(6/2009, Topic of the year ) - Podľa medzinárodnej akademickej nadácie R3i prináša ACCORD Lipid novú nádej diabetikom 2. typu s aterogénnou dyslipidémiou
MUDr. Ľubomíra Fábryová, PhD.
(2/2010, Topic of the year ) - The role of fibrates in a statin world
MUDr. Ľubomíra Fábryová, PhD.
(11/2009, Topic of the year ) - Prehľad aktuálnych európskych (ESH/ESC 2003) a amerických (JNC 7) odporúčaní pre liečbu hypertenzie
MUDr. Jozef Bulas, CSc.
(3/2004, Topic ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - The Importance of Omega – 3 Fatty Acids in the Treatment of Dyslipidemia
prof. MUDr. Daniel Pella, PhD.
(12/2009, Topic of the year ) - Obesity and cardiovascular system
doc. MUDr. Štefan Farský, CSc., FESC
(5/2010, Review articles ) - Komentár k odporúčaniam ACC/AHA (ACC/AHA Guidelines on the Treatment of Blood Cholesterol)
MUDr. Ľubomíra Fábryová, PhD., prof. MUDr. Andrej Dukát, CSc., FESC
(2/2014, Information & comments ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - CLIMACTERIC AND THE CARDIOVASCULAR SYSTEM
MUDr. Ján Števlík
(6/2006, Main topic ) - NOVÉ TRENDY V PREVENCII ATEROSKLERÓZY
(3/2007, Events ) - TREATMENT OF ARTERIAL HYPERTENSION IN ELDERLY PEOPLE AND IN DEMENTIA PREVENTION
prof. MUDr. Zoltán Mikeš, DrSc.
(7-8/2006, Main topic ) - Správa zo XIV. slovenských obezitologických dní s medzinárodnou účasťou
MUC. Michal Pečík
(5/2016, Events ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - The review of clinical and preclinical studies about the effects of Chlorella pyrenoidosa and young barley leaves on organism
doc. MUDr. Martin Péč, PhD., doc. MUDr. Renata Péčová, PhD., Doc. RNDr. Peter Kubatka, PhD.
(5/2015, Review articles ) - Reach target LDL cholesterol more effective dose of atorvastatin 30 mg in the practice of general practitioners
MUDr. Martin Čaprnda, PhD., MUDr. Ján Hencel, MSc., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2015, Original articles & case reports ) - Risk factors of atherosclerosis: lipids and their relation to atherosclerosis
MUDr. Branislav Vohnout, PhD., doc. MUDr. Katarína Rašlová, CSc.
(3/2009, Topic of the year ) - Physical exercise – mandatory part of complex dyslipidemia managment
prof. MUDr. Dušan Meško, PhD.
(7-8/2009, Topic of the year ) - Dietary principles of treatment of obesity
MUDr. Viera Kissová, PhD.
(3/2015, Topic of the year ) - DIABETIC DYSLIPIDAEMIA – IMPORTANT PART OF THE COMPLEX CARE FOR THE PATIENTS WITH DIABETES TYPE 2
MUDr. Ľubomíra Fábryová
(1/2005, Topic ) - MEDICÍNA PRE PRAX – SPRÁVA Z 3. ROČNÍKA KONGRESU LEKÁROV PRVÉHO KONTAKTU
Mgr. Andrea Dúbravčíková, redaktorka časopisu Via Practica
(10/2007, Events ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - HORMONAL CONTRACEPTION IN FAMILY PLANNING – OPTIONS, RISKS AND BENEFITS
MUDr. Michaela Lattáková, PhD.
(4-5/2008, Topic ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - Metabolic changes after bariatric surgery
MUDr. Pavol Holéczy, CSc., Mgr. Marek Bužga, PhD.
(2/2016, Topic of the year ) - MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME
prof. MUDr. Daniel Pella, PhD., doc. MUDr. Viola Mechírová, CSc.
(S4/2007, Supplement ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Pán doktor, príďte! Zápisky lekára po 100 rokoch
MUDr. Jozef Jakuš
(4/2005, Relax ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - PROBLEMS WITH PREVENTION AND DIAGNOSTICS OF DIABETES MELLITUS TYPE 2
doc. MUDr. Eva Valovičová, CSc.
(1/2005, Topic ) - XV. medzinárodné sympózium – Drugs Affecting Lipid Metabolism – DALM
MUDr. Ľubomíra Fábryová
(1/2005, Spectrum ) - ALCOHOL AND DIABETES MELLITUS
MUDr. Jiří Mudra, doc. MUDr. Zdeněk Rušavý
(1/2005, Topic ) - POSSIBILITIES OF DIAGNOSIS AND TREATMENT OF LIPIDS DISORDERS IN AMBULANCE OF GENERAL PRACTITIONER
MUDr. Ľubomíra Fábryová
(6/2005, clearly ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Significance of combined hypolipidemic therapy for patients with metabolic syndrome
MUDr. Renáta Palmajová
(3/2010, Original articles & case reports ) - Ischemická choroba srdca a športová aktivita
prof. MUDr. Dušan Meško, PhD.
(7-8/2005, Consilium ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - LONGTERM CARE AFTER ACUTE CORONARY SYNDROME WITHOUT ELEVATION OF ST-SEGMENT IN PRACTITIONER`S OFFICE
MUDr. Eva Baranová
(5/2007, Topic ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - PREVENTION OF THE ISCHEMIC HEART DISEASE
MUDr. Milan Luknár, MUDr. Branislav Líška
(4/2005, Topic ) - PHARMACOTHERAPY OF OBESITY
prof. MUDr. Juraj Payer, CSc., MUDr. Adriana Petrusová
(12/2005, Topic ) - Epidemiology and health consequences of obesity
MUDr. Ľubomíra Fábryová, PhD.
(1/2015, Topic of the year ) - Obstructive sleep apnea syndrome and obesity
MUDr. Imrich Mucska
(6/2016, Topic of the year ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Srovnání účinnosti semi-generického a originálního atorvastatinu
doc. MUDr. Richard Češka, CSc., prof. MUDr. Helena Vaverková, CSc., as. MUDr. Michal Vrablík, PhD., Jitka Housová, Tomáš Štulc, Željko Reiner, Zvonimir Rumboldt
(5/2005, Spectrum ) - Pilotný projekt vyhľadávania závažných dyslipoproteinémií v slovenskej populácii 40-ročných – dizajn štúdie
MUDr. Ľubomíra Fábryová, doc. MUDr. Rašlová Katarína, CSc.
(2/2004, Focus ) - Stretnutie odborníkov s členmi Spoločnosti familiárnych hyperlipoproteinémií
MUDr. Ľubomíra Fábryová, PhD., MUDr. Eva Rajecová, doc. MUDr. Jana Sirotiaková, CSc.
(1/2010, Events ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - The role of diet therapy in complex treatment of dyslipoproteinemias
MUDr. Viera Kissová, PhD.
(9/2009, Topic of the year ) - XIV. medzinárodné sympózium o ateroskleróze v Ríme
MUDr. Ľubomíra Fábryová
(9/2006, Events ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - OBESITY AND TYPE 2 DIABETES (DIABESITY) – TWO CLOSELY RELATED, PREVENTABLE DISEASES IS THE THERAPY OF OBESITY TOOL FOR PREVENTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES?
MUDr. Ľubomíra Fábryová
(12/2006, Topic ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year ) - Prediabetes
Doc. MUDr. Katarína Gazdíková, PhD., MHA, MPH, mim. prof.
(1/2017, Review articles ) - Diabesity, an increasing medical problem – diabetologist must be therefore also an obesitologist
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD.
(4/2016, Topic of the year ) - Possibilities of prevention of type 2 diabetes mellitus in individuals with prediabetic dysglycemias
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2016, Review articles ) - Classification of dyslipoproteinaemias: Part I – Primary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(5/2009, Topic of the year ) - Artériová hypertenzia – epidemiológia (regionálny a etnický profil) a prevencia, komplikácie, liečebné aspekty
doc. MUDr. Marian Sninčák, CSc., mim. prof.
(5/2014, Events ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic )
- METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - The effect of antidepressants on serum lipid parameters
MUDr. Dagmar Breznoščáková, Mgr. Martina Chylová, PhD., Klára Maceková
(4/2011, Original articles & case reports ) - ANTIPSYCHOTIKA VERSUS REŽIMOVÉ FAKTORY: VLIV NA HMOTNOST HOSPITALIZOVANÝCH PACIENTŮ
MUDr. Vlasta Hanušková, MUDr. Martin Hýža, MUDr. Svatopluk Sedláček, RNDr. Jiří Létal, Ph.D.
(2/2008, Case reports ) - Metabolic syndrome in bipolar disorder
MUDr. Jan Hubeňák
(4/2016, Review articles ) - Aging of a woman and hormonal replacement therapy
prof. MUDr. Jaroslav Živný, DrSc.
(6/2004, Review articles ) - Atypical antipsychotics and diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(1/2013, Review articles ) - Metabolic syndrome in the context of psychiatric disorders and psychotropic treatment
MUDr. Jozef Dragašek, PhD.
(1/2014, Review articles ) - PRAKTICKÉ TIPY PRO SLEDOVÁNÍ BEZPEČNOSTI PŘI DLOUHODOBÉ LÉČBĚ ANTIPSYCHOTIKY
MUDr. Jiří Masopust
(4/2007, In short ) - Prevention of cardiovascular risk and diabetes in schizophrenia patients: application of internet in clinical praxis
MUDr. Jiří Masopust, Ph.D., MUDr. Radovan Malý, Ph.D.
(5–6/2010, In short ) - ANTIPSYCHOTICS TREATMENT AND METABOLIC SYNDROME
MUDr. Dita Kalnická, prof. MUDr. Jan Libiger, CSc.
(5/2006, Review articles ) - Safety monitoring of the treatment with risperidone in children and adolescents
prof. MUDr. Ivana Drtílková, CSc.
(2/2016, Digital publications ) - METABOLIC SYNDROME IN PSYCHIATRY
doc. MUDr. Vladimír Pidrman, Ph.D., doc. MUDr. Jiří Horáček, CSc.
(5/2005, Review articles ) - DEPRESSION, METABOLIC SYNDROME AND DIABETES MELLITUS
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(2/2006, Review articles )
- Diabetes mellitus: současný pohled na patogenezi, klasifikaci a léčbu
prof. MUDr. Michal Anděl, CSc.
(1/2007, From the boundary of neurology ) - Risk conditions in patients at chronic stage of spinal cord injury
MUDr. Jiří Kříž, MUDr. Veronika Hyšperská
(3/2009, Main topic ) - Adult-onset huntington disease phenocopies
doc. MUDr. Jan Roth, CSc., MUDr. Martin Kucharík, MUDr. Jiří Klempíř, Ph.D.
(3/2009, Review articles ) - Publikujeme v zahraničí
doc. MUDr. Milan Brázdil, Ph.D. , MUDr. Roman Herzig, Ph.D.
(5/2006, Papers from literature ) - Idiopatická ľahká kognitívna dysfunkcia
doc. MUDr. Egon Kurča, PhD.
(1/2004, Main topic ) - Genetic causes of parkinsonism with focus on spinocerebellar ataxias
MUDr. Matej Škorvánek, doc. MUDr. Peter Valkovič, PhD.
(3/2012, Main topic ) - Neurologické projevy poruch metabolizmu lipidů
doc. MUDr. Ivanka Vlachová
(1/2005, Main topic ) - Stroke in diabetic patients
doc. MUDr. Jaromír Chlumský, Ph.D., prof. MUDr. Jindra Perušičová, DrSc., prof. MUDr. Milan Kvapil, CSc.
(1/2010, From the boundary of neurology ) - Statins and neuroprotective effects
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN, PharmDr. Aleš Dvořák, MBA
(1/2021, Review articles ) - Alzheimer’s disease and type 2 diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(2/2012, From the boundary of neurology ) - Epilepsy and metabolic syndrome X
MUDr. Irena Novotná
(3/2011, Review articles )
- Metabolic syndrome in children and its diagnostic problems
prof. MUDr. László Kovács, DrSc., MPH, doc. MUDr. Ľudmila Košťálová, CSc., mim. prof., MUDr. Zuzana Pribilincová, CSc., MUDr. Anna Hlavatá, PhD., MUDr. Eva Vitáriušová, PhD., MUDr. Katarína Babinská, ml.
(3/2011, Original articles ) - Komplex metabolic changes in children with obesity
MUDr. Zlatko Marinov, MUDr. Dalibor Pastucha, Ph.D., MBA
(2/2012, Review articles ) - THE TREATMENT WITH GROWTH HORMONE IN CHILDHOOD
doc. MUDr. Ľudmila Košťálová, CSc.
(4/2008, Review articles ) - Utilisation of omega fatty acids in pedopsychiatry
MUDr. Jana Trebatická, PhD., Mgr. Magdaléna Vaváková
(3/2015, Review articles ) - Risk factors of atherosclerosis in childhood
MUDr. Pavol Šimurka, PhD.
(5/2010, Review articles ) - Health and psychosocial consequences of obesity in children and adolescents
MUDr. Irena Aldhoon Hainerová, Ph.D., RNDr. Hana Zamrazilová, Ph.D.
(3/2016, Review articles ) - LIPIDS IN CHILDHOOD NUTRITION
MUDr. Pavel Frühauf, CSc.
(1/2008, Review articles ) - Vyšetření a sledování dětí s hypercholesterolémií
doc. MUDr. Zuzana Urbanová CSc.
(2/2005, Information & comments ) - ANABOLIC STEROIDS AND YOUNG
MUDr. Pavol Šimurka, MUDr. Martin Zavřel
(6/2008, Review articles ) - Recommendations for diagnosis and treatment of dyslipidaemia in children and adolescents
MUDr. Ľubomíra Fábryová, PhD., MUDr. Anna Hlavatá, PhD.
(S1/2011, Review articles )
- Správa z X. Košických chemoterapeutických dní, 23. – 24. november 2006
MUDr. Radovan Barilla
(1/2007, Events )
- Impact of life style change to biochemical parameters in psoriasis patients
MUDr. Zuzana Rajczyová, Ing. Pavel Blažíček, CSc., prof. MUDr. Mária Šimaljaková, PhD., MHA
(1/2016, Original articles & case reports ) - Cardiovascular diseases and psoriasis
MUDr. Zuzana Baranová, PhD.
(3/2016, Review articles ) - Comorbidities in psoriasis – a new perspective of an old disease
doc. MUDr. Vladimír Vašků, CSc.
(3/2009, Review articles )
- POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(3-4/2007, clearly ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles ) - OBESITY MANAGEMENT IN AMBULATORY PRACTICE
MUDr. Peter Minárik, MUDr. Dušan Ogurčák
(2/2008, Review articles )
- New drugs registered in the EU in 2015 (III.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3/2016, New drugs ) - Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Contribution of the pharmacist in the prevention and treatment of certain risk factors for cardiovascular disease
Mgr. Anita Šestáková
(4/2016, Clinical pharmacy ) - The 42nd Days of Pharmacy with main topic „Diabetes“ – epidemic of the third millennium
doc. RNDr. Magdaléna Fulmeková, CSc.
(2/2016, Events ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Medicinal plants in prevention of cardiovascular diseases
PharmDr. Szilvia Czigle, PhD., Mgr. Jaroslav Tóth, PhD.
(1/2014, Phytotherapy ) - Niacin-laropiprant combination: novel approach not only to treatment of dyslipidemia Complex management of dyslipidemia provides a chance of further reduction of atherosclerotic vascular
MUDr. Michal Vrablík, Ph.D., MUDr. Eva Motyková, prof. MUDr. Richard Češka, CSc.
(1/2011, New medicinal substances ) - Modifying cholesterol level with plant substances
PharmDr. Miloš Potužák
(1/2011, Phytotherapy ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy ) - Age related macular degeneration
doc. MUDr. Tomáš Sosna, CSc., MUDr. Magdalena Netuková, Ph.D., MUDr. Petra Sedláčková, MUDr. Radka Švancarová
(2/2011, Current pharmacotherapy ) - Cholesterol z hľadiska životosprávy
PhDr. Marta Martinčeková
(4/2013, For pharmaceutical laboratory technicians )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic ) - Pharmacological treatment of peripheral arterial disease of lower limbs from a vascular surgeon’s point of view
prof. MUDr. Vladimír Šefránek, PhD.
(3-4/2012, Review articles ) - Prevention and non-pharmacological treatment of arterial disease
prof. MUDr. Viera Štvrtinová, CSc., doc. MUDr. Ľudovít Gašpar, CSc., prof. MUDr. Andrej Dukát, CSc., FESC, MUDr. Denisa Čelovská, PhD.
(1/2014, Review articles ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes ) - Markers of vulnerable plaque in atherosclerotic internal carotid artery affected
MUDr. Mária Kubíková, PhD., MUDr. Pavel Staško, PhD., MUDr. Peter Štefanič, MUDr. Peter Berek, PhD., MUDr. Ivan Kopolovets, MUDr. Jana Pobehová, PhD.
(1/2016, Main topic ) - XXII. SLOVENSKÝ ANGIOLOGICKÝ KONGRES s medzinárodnou účasťou
(S3/2014, Supplement )
- Perioperative management of obese patient
MUDr. Monika Grochová, PhD., MUDr. Štefan Trenkler, PhD., doc. MUDr. Jozef Firment, PhD.
(2/2013, Review articles )